MnO2-melittin nanoparticles serve as an effective anti-tumor immunotherapy by enhancing systemic immune response.
Biomaterials
; 288: 121706, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35953328
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cancer Vaccines
/
Nanoparticles
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Biomaterials
Year:
2022
Type:
Article
Affiliation country:
China